€100,000 investment opportunity for central nervous system research

Zcube, a research venture of Italian pharmaceutical company Zambon, has invited researchers, scientists and aspiring entrepreneurs to apply for its third international Open Accelerator programme.

The programme – which runs for 12 weeks at the Openzone campus in Milan, Italy – will have a specific focus on the therapeutic areas of the central nervous system and the respiratory system, including rare diseases in these two areas. Upon completing the accelerator, participants will have the chance to win seed investment of up to €100,000 to develop their projects in collaboration with Zambon.

Elena Zambon, president of Zambon, said: “Open Accelerator is a fundamental ‘school’ teaching young researchers how to communicate with the business world and venture capitalists and to take their ideas out of the laboratories and let them become effective opportunities to improve patients’ lives.”

Submissions for the accelerator programme are open until 30 June 2018.